These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 22330060)
1. Attenuation of murine graft-versus-host disease by a tea polyphenol. Kanamune J; Iwanaga Y; Kina T; Noguchi H; Matsumura K; Uemoto S; Hyon SH Cell Transplant; 2012; 21(5):909-18. PubMed ID: 22330060 [TBL] [Abstract][Full Text] [Related]
2. Tea polyphenol inhibits allostimulation in mixed lymphocyte culture. Kim JY; Kina T; Iwanaga Y; Noguchi H; Matsumura K; Hyon SH Cell Transplant; 2007; 16(1):75-83. PubMed ID: 17436857 [TBL] [Abstract][Full Text] [Related]
3. Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference. Sang W; Zhou C; Cheng N; Li Z; Zeng L; Xu K Immunol Lett; 2011 May; 136(2):194-202. PubMed ID: 21277900 [TBL] [Abstract][Full Text] [Related]
4. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment. Drobyski WR; Majewski D; Ozker K; Hanson G J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation. Zeng M; Guinet E; Nouri-Shirazi M Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560 [TBL] [Abstract][Full Text] [Related]
7. Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect. Ilan Y; Margalit M; Ohana M; Gotsman I; Rabbani E; Engelhardt D; Nagler A Hum Immunol; 2005 Mar; 66(3):231-40. PubMed ID: 15784461 [TBL] [Abstract][Full Text] [Related]
8. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier. Blazar BR; Taylor PA; Snover DC; Bluestone JA; Vallera DA J Immunol; 1993 Jan; 150(1):265-77. PubMed ID: 8417127 [TBL] [Abstract][Full Text] [Related]
9. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. Krenger W; Snyder KM; Byon JC; Falzarano G; Ferrara JL J Immunol; 1995 Jul; 155(2):585-93. PubMed ID: 7608537 [TBL] [Abstract][Full Text] [Related]
10. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells. Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625 [TBL] [Abstract][Full Text] [Related]
11. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation. Li JM; Gorechlad J; Larsen CP; Waller EK Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205 [TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity and responsiveness to recombinant interleukin-2 of effector cells of graft vs. host disease and mixed lymphocyte reaction in mice. Stark J; Weiss L; Slavin S Isr J Med Sci; 1992 Nov; 28(11):767-72. PubMed ID: 1468887 [TBL] [Abstract][Full Text] [Related]
13. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease. Drobyski WR; Majewski D; Hanson G Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102 [TBL] [Abstract][Full Text] [Related]
14. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. Johnson BD; Becker EE; LaBelle JL; Truitt RL J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039 [TBL] [Abstract][Full Text] [Related]
15. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution. Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113 [TBL] [Abstract][Full Text] [Related]
16. Immune cell activation and subsequent epithelial dysfunction by Staphylococcus enterotoxin B is attenuated by the green tea polyphenol (-)-epigallocatechin gallate. Watson JL; Vicario M; Wang A; Moreto M; McKay DM Cell Immunol; 2005 Sep; 237(1):7-16. PubMed ID: 16213476 [TBL] [Abstract][Full Text] [Related]
17. Contribution of B7RP-1/ICOS co-stimulation to lethal acute GVHD. Fujimura J; Takeda K; Kaduka Y; Saito M; Akiba H; Yagita H; Yamashiro Y; Shimizu T; Okumura K Pediatr Transplant; 2010 Jun; 14(4):540-8. PubMed ID: 20136724 [TBL] [Abstract][Full Text] [Related]
18. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995 [TBL] [Abstract][Full Text] [Related]
19. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice. Blazar BR; Taylor PA; Vallera DA J Immunol; 1994 Apr; 152(7):3665-74. PubMed ID: 8144942 [TBL] [Abstract][Full Text] [Related]
20. Expression level of costimulatory receptor ICOS is critical for determining the polarization of helper T cell function. Watanabe S; Ogawa S; Hara Y; Tanabe K; Toma H; Abe R Transpl Immunol; 2006 Apr; 15(4):255-63. PubMed ID: 16635747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]